bpc-157 administration oral subcutaneous Dosage Protocol: Injection Guide This is the first vote

Unlike short-lived growth-factor peptides, it is notably stable in gastric juice, and laboratories study it as a stable pentadecapeptide tool compound in tissue-repair and cytoprotection research

This implies simultaneous healing of the different tissues (i.e., fistula healing [2], but also myotendinous junction recovery [43]), and thereby particular wound healing potential [1,9], providing a particular potential for the recovery of damaged muscle function [2,19,20,21,22,25,28,29,30,31,43,44,45,46,47,48]

By targeting healing where it actually happens, at the cellular level, BPC-157 promotes faster recovery and improved tissue function

The subcutaneous route is used at much smaller doses than oral because a 100 mg injection would require two 50 mg vials and about 6 mL of liquid when each vial is mixed with 3.0 mL BAC water, which is too much for one subcutaneous site